| suPAR | soluble urokinase plasminogen activator receptor |
| uPAR | urokinase plasminogen receptor |
| mRS | modified Rankin Scale |
| CRP | C-reactive protein |
| PCT | procalcitonin |
| NT-proCNP | N-terminal pro C-type natriuretic peptide |
| ELISA | enzyme-linked immunosorbent assay |
| CVD | cardiovascular disease |
| DM2 | type 2 diabetes mellitus |
| CVE | cardiovascular events |
| TIA | transient ischemic attack |
| SVD | small vessel disease |
| CT | computer tomography scan |
| MRI | magnetic resonance imaging |
| TOAST | trial of ORG 10172 in acute stroke treatment |
| ASA | acetylsalicylic acid |
| ECG | electrocardiograph |
| LAO | large artery occlusion |
| ESUS | embolic stroke of undetermined source |
| SD | standard deviation |
| HbA1C | glycated hemoglobin |
| HDL | high-density lipoprotein |
| LDL | low-density lipoprotein |
| NIHSS | National Institute of Health Stroke Scale |
| AF | atrial fibrillation |
| LASSO | least absolute shrinkage and selection operator |